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The rewarding effects of opiates are thought to be mediated
through dopaminergic mechanisms in the ventral tegmental
area, dopamine-independent mechanisms in the nucleus ac-
cumbens, or both. The purpose of the present study was to
explore the contribution of dopamine to opiate-reinforced be-
havior using D2 receptor knock-out mice. Wild-type, heterozy-
gous, and D2 knock-out mice were first trained to lever press
for water reinforcement and then implanted with intravenous
catheters. The ability of intravenously delivered morphine to
maintain lever pressing in these mice was studied under two
schedules of reinforcement: a fixed ratio 4 (FR4) schedule
(saline, 0.1, 0.3, or 1.0 mg/kg, per injection) and a progressive
ratio (PR) schedule (1.0 mg/kg, per injection). In the wild-type
and heterozygous mice, FR4 behavior maintained by morphine
injections was significantly greater than behavior maintained by
vehicle injections. Response rate was inversely related to injec-
tion dose and increased significantly in the wild-type and het-
erozygous mice when the animals were placed on the PR
schedule. In contrast, the knock-out mice did not respond more
for morphine than for saline and did not respond more when
increased ratios were required by the PR schedule. Thus, mor-
phine served as a positive reinforcer in the wild-type and het-
erozygous mice but failed to do so in the knock-out mice.
Under this range of doses and response requirements, the
rewarding effects of morphine appear to depend critically on an
intact D2 receptor system.
Key words: self-administration; morphine; dopamine; D2 re-
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The mesolimbic dopamine system has been implicated in the
rewarding effects of both the opiates and the psychomotor stim-
ulants (Wise, 1998). Direct localized administration of opioids to
the ventral tegmental area (VTA) and the nucleus accumbens
(NAc) have reinforcing effects (Bozarth and Wise, 1981; Olds,
1982; Goeders et al., 1984; Devine and Wise, 1994). Morphine
self-administration into the VTA is thought to be mediated by a
dopamine-dependent mechanism, whereas morphine self-
administration into the NAc is thought to be mediated by a
dopamine-independent mechanism. Local injections of opiates in
the VTA are thought to act by inhibiting GABAergic neurons
that normally suppress the activity of their dopaminergic neigh-
bors (Johnson and North, 1992). Disinhibition of the dopamine
projection neurons increases dopamine levels in the NAc which
then decreases medium spiny output neuron activity. Local in-
jections of opiates in NAc are thought to act independently of
local dopaminergic terminals by directly decreasing the activity of
GABAergic medium spiny output neurons (Hakan and Henrik-
sen, 1989; Jiang and North, 1992; Wang et al., 1997). The relative
importance of these two sites (dopamine-dependent VTA and
dopamine-independent NAc) in the positive reinforcing effects of
intravenous opiates is not clearly established.
Genetically engineered animals offer one of the more recently
available techniques to be applied to neuropharmacological re-
search. Although a substantive role for the -opiate receptor in
intravenous opiate self-administration has been demonstrated
using knock-out (Becker et al., 2000; Sora et al., 2001), transgenic
(Elmer et al., 1996), and  receptor-deficient mice (Elmer et al.,
1995), the role of dopamine has not been examined using dopa-
mine receptor-deficient mice in the self-administration model. In
the three studies that have used dopamine-related knock-out
models, all have used the conditioned place preference (CPP)
method to assess reward. Morphine-induced CPP in dopamine
transporter knock-out mice is stronger than that in wild-type
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mice (Spielewoy et al., 2000). Two studies have used dopamine
D2 receptor knock-out mice. One group found that previously
drug-naive D2 receptor knock-out mice failed to show CPP after
conditioning (Maldonado et al., 1997), whereas the other group
found that previously drug-naive D2 receptor knock-out mice did
show CPP (Dockstader et al., 2001).
The discrepancy between the two D2 knock-out studies and the
unknown relationship between CPP and instrumental drug self-
administration leaves open the question of the relative impor-
tance of dopamine-dependent and dopamine-independent mech-
anisms in the positive reinforcing effects of opiates. The purpose
of the present study was to explore the consequences of D2
dopamine receptor elimination on intravenous morphine self-
administration. The control of lever pressing behavior by intra-
venous morphine was assessed in D2 knock-out, wild-type, and
heterozygous mice under two conditions: across three morphine
doses in a fixed-ratio (FR) paradigm and at the highest of these
doses in a progressive ratio (PR) paradigm.
MATERIALS AND METHODS
Animals
Adult (60–120 d old) male dopamine D2 receptor knock-out (n  13),
heterozygous (n 16), and wild-type (n 20) mice weighing21–30 gm
at the start of the experiment were used. The homologous recombination
techniques and genealogy are described in detail in previous reports
(Kelly et al., 1997, 1998). Briefly, a vector in which the 5 half of exon 8
was eliminated (sequences encoding the sixth transmembrane domain
through the C terminus) was electroporated into a D3 embryonic stem
(ES) cell line (129/Sv derived). Positive clonal ES cells were injected into
C57BL/6J blastocysts. Male chimerics were bred to C57BL/6J females to
produce a heterozygous F1 population. These mice were then interbred
to produce an F2 offspring with a slightly atypical Mendelian distribution
of 1:5. Subsequently, D2 heterozygous mice were backcrossed to wild-
type C57BL/6J mice for a number of generations. The mice used in the
current study were from the 10th generation.
All animals were experimentally naive, housed in groups of two to five
in a temperature-controlled room (21°C) with a 12 hr light /dark cycle,
and given ad libitum access to Purina Laboratory Chow and tap water
before the start of the experimental procedure. The animals used in this
study were maintained in facilities fully accredited by the American
Association for the Accreditation of Laboratory Animal Care. The
studies were conducted in accordance with the Guide for Care and Use of
Laboratory Animals provided by the National Institutes of Health.
Operant morphine-reinforced behavior
Procedure overview. The following procedures were used to assess oper-
ant intravenous morphine self-administration behavior. First, all mice
were trained on a modified progressive ratio schedule for water rein-
forcement. This procedure was used to confirm the ability of the knock-
out mice to learn and perform a lever press operant for a non-drug
reinforcer. The modified progressive ratio was used to assess the range of
lever pressing rates that could be expected from the various genotypes.
Second, some of the water-trained mice were surgically implanted with
intravenous catheters and then allowed to respond on an FR4 schedule of
reinforcement for 1.0, 0.3, 0.1, and then 0 mg/kg morphine. Data from
these tests were used to determine whether morphine would maintain
responding in a dose-dependent manner. The remaining water-trained
mice were surgically implanted with intravenous catheters and then
placed on a progressive ratio schedule of morphine reinforcement. Mice
were randomly assigned to each schedule. Data from these experiments
were used to make an initial determination of potential differences in the
efficacy of our test dose of morphine as a reinforcer in the different
genotypes.
Apparatus. Ten mouse operant chambers were used. Each chamber was
equipped with one lever, a liquid solenoid, and a 22 ga liquid swivel. The
lever was a balanced rocker arm that broke an infrared photo beam when
0.5 gm of force was applied. Two stimulus lights were used: one was
positioned to illuminate the translucent lever, and the other was posi-
tioned above the solenoid delivery spout. The lever light was illuminated
during periods of drug availability; the second light was illuminated
during drug delivery. During water training, lever pressing resulted in
delivery of a drop (5 l) of water after completion of each fixed-ratio
component. A Harvard 22 l syringe pump was used to deliver vehicle or
drug. The syringe pump and stimulus lights were controlled by an
integrated Coulborn (Allentown, PA) environmental control system and
MedAssociates interface (St. Albans, VT). System control and data
acquisition and storage were accomplished using MedAssociates
software.
Water training. Naive subjects were water deprived for 24 hr and then
placed in the operant chamber. Initially, a single lever press turned on
stimulus lights above a spout (FR1); a solenoid delivery system delivered
a small amount of liquid in response to each lever press. After completion
of each 50 reinforcements, there was an increase in the fixed ratio
requirement (FRX  1). The experimental sessions were run 24 hr/d for
4 d with ad libitum access to food.
Surgery. After completion of the water training, subjects were surgi-
cally prepared with a catheter implanted in the jugular vein. Surgical
procedures were performed under ketamine (80 mg/kg, i.p.)- and xyla-
zine (16 mg/kg, i.p.)-induced anesthesia. SILASTIC tubing (0.012 inch
inner diameter) was implanted in the right jugular vein approximately to
the level of the atrium. The catheter was passed subcutaneously and
exited in the midscapular region. The catheter was connected to a
tether/swivel system that was mounted to the skull of the mouse with
dental cement. Subjects recovered full movement and eating and drink-
ing habits 3–5 d after surgery. Catheter patency was checked at the end
of the experimental protocols via acute dosing with pentobarbital. Only
those animals with patent catheters were included in the analysis.
Morphine self-administration behavior: fixed ratio 4 dose–effect curve.
After recovery from surgery (3–5 d), subjects [n  12, 10, and 7 for the
D2 wild-type (D2wt), D2 heterozygous (D2het), and D2 knock-out
(D2ko) mice, respectively] were placed in the operant chamber and given
access to 1.0, 0.3, 0.1, and 0 mg/kg morphine per injection for 5, 3, 3, and
8 d, respectively. All subjects were run on an FR4 schedule of reinforce-
ment. Completion of each FR resulted in the illumination of the over-
head house light and stimulus lights above the spout. Injections of 5–8 l
(based on body weight) were given over a period of 15 sec. A 30 sec
time-out period, during which house and stimulus lights were out, fol-
lowed the completion of each injection. All subjects had access to
morphine 23 hr/d and ad libitum access to food and water 24 hr/d. A 12
hr light /dark cycle was maintained (on 7 A.M., off 7 P.M.). A stimulus
light illuminating the lever signaled morphine availability.
Morphine self-administration behavior: progressive ratio performance. In
the second group of mice (n  8, 6 and 6 for the D2wt, D2het, and D2ko
mice, respectively), subjects were placed in the operant chamber after
surgery (3–5 d) and given access to 1.0 mg/kg morphine per injection for
7 d on an FR4 schedule of reinforcement. These subjects were then
placed on a progressive ratio schedule. Completion of each ratio resulted
in an increase in the ratio requirement to obtain the next reinforcement.
The sequential ratio requirements were adapted from Roberts and Ben-
net (1993) and were as follows: PR (1, 3, 5, 7, 9, 12, 15, 18, 23, 28, 33, 41,
49, 57, 70, 83, 96, 117, 138, 156, 200, 225, 275, 300, 325, 350, 375, 425, 475,
525, 600). The experimental sessions were run 12 hr/d (8 P.M.– 8 A.M.)
with ad libitum access to food and water. A 12 hr light /dark cycle was
maintained (on 7 A.M., off 7 P.M.). Animals remained in the operant
chamber for the duration of the experiment. A stimulus light illuminating
the lever signaled morphine availability.
Data analysis. Genetic differences in fixed-ratio performance were
analyzed using a two way repeated-measures ANOVA using drug intake
and the number of reinforcements obtained at each dose as dependent
variables. Genetic differences in progressive ratio performance were
analyzed using a two way repeated-measures ANOVA with the number
of reinforcements as the dependent variable. Post hoc analysis for each
schedule of reinforcement was conducted using contrast analysis
(SuperAnova).
RESULTS
Water training
All genotypes were successfully trained to stable rates of lever
pressing for water reinforcement (Fig. 1A), reaching stable water
intake by the second day of responding and maintaining that
intake despite increasing response requirements (Fig. 1B). Al-
though each genotype reached stable response and intake rates,
the D2 knock-out mice emitted fewer responses and consumed
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less water during the water-training period. There was a sig-
nificant overall main effect of genotype for the fixed ratio
obtained (F(Genotype)(2,27)  8.98; p  0.001) and number of
reinforcements (F(Genotype)(2,27)  5.29; p  0.01). Addition-
ally, a genotype by day interaction was found for reinforce-
ments (F(Genotype  Day)(6,78)  2.66; p  0.02). Overall, D2ko
mice consumed significantly less water when required to lever
press to obtain water. When mice were given ad libitum access
to water in their home cages, water consumption did not differ
significantly across the three genotypes (6.0  0.4, 5.0  0.5,
and 6.2  0.4 ml for the D2wt, D2het, and D2ko mice,
respectively). The D2ko animals were clearly capable of lever
pressing at rates of at least 566 responses per day. This would
prove to be 15 the rate of responding sustained under
morphine reinforcement.
Morphine self-administration behavior: fixed ratio 4
dose–effect curve
The response rates of the D2wt and D2het mice were higher for
low doses of drug than for saline (Fig. 2A). Although response
rates for the D2wt and D2het mice decreased with increasing
doses of morphine per injection, the response rates of the D2ko
mice were the same for morphine as for saline and did not vary as
a function of morphine dose. In the D2wt mice, injections of
morphine maintained significantly greater and lesser amounts of
behavior than saline at the 0.1 ( p  0.0367) and 1.0 mg/kg dose
( p  0.0052), respectively. In the D2het mice, the overall main
effect of dose was significant; however, behavior maintained by
the 0.1 mg/kg dose was only marginally greater than behavior
Figure 1. A and B represent the highest fixed ratio completed each day
and the actual number of reinforcements obtained during the water-
training period, respectively. At the start of the water-training protocol, a
single lever press resulted in liquid delivery; thereafter, completion of
each 50 reinforcements resulted in an increase of the fixed ratio require-
ment (FRX  1). The FR requirement was set to the previous day’s last
FR on days 2, 3, and 4. Each point represents the condition mean (SEM)
of results from 12 D2wt, 10 D2het, and 7 D2ko mice.
Figure 2. Lever pressing behavior (A) and drug intake (B) as a function
of increasing morphine dose per injection. Each point represents the
condition mean (SEM) of results from 12 D2wt, 10 D2het, and 7 D2ko
mice over the last three sessions of each condition. # represents a
significant difference from the saline control level of each genotype;‚ p
0.06 from saline control; * indicates a significant difference from wild
type.
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maintained by saline ( p  0.0936), whereas behavior maintained
by the 1.0 mg/kg dose was significantly less ( p  0.0328). In the
D2ko mice, there was no significant difference between lever
pressing for saline and lever pressing for morphine; furthermore,
there were no significant differences in the responding across the
three morphine dose conditions ( p  0.63; NS). Morphine intake
in the D2ko mice was predictable from the rate of responding
under saline reinforcement; the animals made the same 35 or so
responses per day regardless of morphine dose and passively
received the amount of drug that accompanied that number of
responses at each dose (Fig. 2 B). The overall main effects of
dose, genotype, and genotype  dose interaction were signif-
icant for the number of lever presses maintained by morphine
injections: F(Dose)  10.93, df  3,78, p  0.0001; F(Genotype) 
3.77, df  2,78, p  0.02; F(Genotype  Dose)  2.37, df  6,78,
p  0.036. There was a dose-related change in the amount of
behavior maintained at each dose in the D2wt (F(Dose)  9.30,
df  3,33, p  0.0001) and D2het mice (F(Dose)  5.37, df  3,33,
p  0.005). There was a significant main effect of genotype and
dose and a significant genotype  dose interaction on drug
intake: F(Genotype)  2.7, df  2,23, p  0.02; F(Dose)  8.7, df 
2,23, p  0.002; F(Genotype  Dose)  7.8, df  4,23, p  0.03.
Morphine self-administration behavior: progressive
ratio performance
Under progressive ratio conditions, the D2wt and D2het animals
increased their response rates as response demands increased,
whereas the D2ko animals responded no more on the progressive
ratio schedule than they had responded for either saline or mor-
phine on the FR schedule (Fig. 3). Lever pressing increased
significantly in the D2wt and D2het mice but not in the D2ko
mice ( p  0.02, p  0.02, p  0.24, respectively). The overall
main effects of schedule and genotype as well as the genotype by
schedule interaction for the number of injections received were
significant: (F(Schedule)(1,17)  16.9, p  0.0008; F(Genotype)(2,17) 
5.77, p 0.02; F(Genotype  Schedule)(1,17) 3.3, df 1,17, p 0.05.
Thus, in the D2ko animals, morphine again failed to sustain levels
of responding greater than those sustained by saline. Under saline
or morphine conditions (any dose or schedule), the D2ko animals
responded at1/10 the rates that had been sustained under water
reinforcement.
DISCUSSION
Intravenous morphine delivery did not serve as a positive rein-
forcer in dopamine D2 receptor knock-out mice under conditions
that were effective in the wild-type and heterozygous mice. D2ko
mice responded at the same low levels for intravenous saline and
intravenous morphine and did not alter their rate of responding
when morphine doses were altered. D2wt and D2het mice re-
sponded at increased rates for the low dose of morphine and at
decreased rates for the high dose of morphine. Thus the behavior
of the D2wt and D2het animals was under the pharmacological
control of morphine, whereas the behavior of the D2ko animals
was not. That the D2ko animals were capable of responding more
than they did for morphine seems clear from their level of
responding for water during the water-training period. That they
were not incapacitated by the morphine itself was clear from the
fact that the same low rate of responding seen with intravenous
saline was also seen with intravenous morphine. Thus morphine
served effectively as a reinforcer in D2wt and D2het mice, but
served no more effectively than intravenous saline reinforcement,
and much less effectively than oral water reinforcement, in D2ko
mice. Across the normally effective dose range, intravenous mor-
phine seems unable to serve as a normal reinforcer in D2ko mice.
Under the conditions described in this report, the rewarding
effects of morphine appear to depend on an intact or a partially
intact D2 receptor system.
Previous dialysis and voltammetry studies have suggested in-
volvement of dopamine in morphine-reinforced behavior (Di
Chiara and Imperato, 1988; Devine et al., 1993; Wise et al., 1995;
Kiyatkin and Rebec, 2001). These studies, however, are correla-
tive in nature and do not provide evidence that would identify
which component of the dopamine system may be involved. Stud-
ies involving dopamine antagonists have not consistently con-
firmed a role for dopamine in opiate reinforcement (Ettenberg et
al., 1982; van Ree and Ramsey, 1987; Gerber and Wise, 1989;
Gerrits et al., 1994). In these studies, which used competitive
dopamine antagonists with varying selectivity for dopamine re-
ceptor subtypes, the completeness of dopamine blockade could
Figure 3. Number of lever presses (A) and reinforcements (B) obtained
under a fixed-ratio 4 and progressive-ratio schedule of reinforcement.
Each point represents the condition mean (SEM) of results from eight
D2wt, six D2het, and six D2ko mice over the last three sessions of each
condition. Asterisk indicates a significant difference from D2wt and D2het
mice; # represents a significant difference from FR4 values.
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not be assessed. Genetically engineered animals provide a model
with partial and complete receptor elimination. Using this model,
the evidence provided in the current study suggests that a 50%
complement of D2 receptors is sufficient to maintain morphine
self-administration, whereas complete elimination of D2 recep-
tors is not.
Conflicting conclusions have been reached using D2 receptor
knock-out mice in CPP models (Maldonado et al., 1997; Docks-
tader et al., 2001). Maldonado et al. (1997) found that drug-naive
D2ko mice did not show morphine-conditioned place prefer-
ences, whereas Dockstader et al. (2001) found that previously
drug-naive D2ko mice did. Neither study investigated CPP in
heterozygote mice. The two studies used similar dose ranges, but
different methods were used to eliminate the D2 receptor genes.
In addition, a mixed genetic background (C57BL 129) was used
in the Maldonado et al., (1997) report, whereas a fifth generation
congenic C57BL/6J background was used in the Dockstader et al.
(2001) report. Differences in background genotype were offered
to explain the discrepancies. However, the animals used in the
present study were the 10th generation of the same knock-out line
that was used by Dockstader et al. (2001). On the basis of further
studies, Dockstader et al. (2001) suggested that CPP failed to
develop in the D2ko mice only if the animals were first made
physically dependent on morphine (Bechara et al., 1992). In the
present study the animals were not opiate-dependent, yet intra-
venous morphine, at any of three normally effective doses, failed
to serve as an effective reinforcer.
Genetically manipulated animal models provide a means to
eliminate a receptor system with a high degree of specificity.
However, embryonic gene manipulation is unlikely to affect a
single behavior or a single receptor system. As an example of
pleiotropic effects on behavior, D2 knock-out mice emitted fewer
responses during the water-training period in addition to the
instrumental morphine reinforced period. Water consumption in
the home cage did not differ significantly across the three groups
of mice. The selective effect on instrumental responding may be
explained by the fact that dopamine antagonists disrupt instru-
mental behaviors at lower doses than are required to disrupt free
consumption of the reward in question (Gramling and Fowler,
1985). The decreased responding in the knock-outs is also con-
sistent with the notion that dopamine plays a fundamental role in
the rewarding impact of food, water, and other positive reinforc-
ers (Wise and Rompre, 1989). The general involvement of D2
receptors in motivated behavior will be important to investigate
further (Risinger et al., 2000). As an example of pleiotropic
effects on neurotransmitters, D2 knock-out mice have reduced
glial cell line-derived neurotrophic factor (Bozzi and Borrelli,
1999), dopamine transporter function (Dickinson et al., 1999),
striatal medium spiny neurons (Cepeda et al., 2001), adenosine
A(2A) receptor function (Zahniser et al., 2000), and substance P
mRNA levels (Murer et al., 2000). One of these secondary alter-
ations may be a necessary cofactor to D2 receptor function in
determining opiate reward (i.e., substance P) (Murtra et al.,
2000). Although several caveats exist with embryonic gene ma-
nipulation, it is important to note that D2 knock-out mice have a
normal complement of -opiate receptors (Maldonado et al.,
1997) and show other opiate-mediated behaviors (Drago et al.,
1999). In addition, the D2ko mice are capable of significant
instrumental responding (i.e., 566 lever presses during the last day
of water-reinforced behavior), but such responding is not sus-
tained by morphine reward. Overall, the evidence provided in this
report clearly supports the conclusion that an intact D2 receptor
system is an important component of opiate reward mechanisms.
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